PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro

Podobné jednotky

• Targeting the cyclin-dependent kinases (CDK) 4/6 in estrogen receptor-positive breast cancers
  Autor: Finn, Richard S., a další
  Vydáno: (2016)
• Identification of common predictive markers of in vitro response to the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in human breast cancer and non-small cell lung cancer cell lines
  Autor: Garon, Edward B., a další
  Vydáno: (2010)
• The CDK4/6 inhibitor PD0332991 reverses epithelial dysplasia associated with abnormal activation of the Cyclin-CDK-Rb pathway
  Autor: Cabrera, M. Carla, a další
  Vydáno: (2012)
• Cell differentiation and dominant signaling pathway signatures in the molecular classification of human breast cancer cell lines
  Autor: Wilson, CA, a další
  Vydáno: (2005)
• HER-2 overexpression differentially alters transforming growth factor-β responses in luminal versus mesenchymal human breast cancer cells
  Autor: Wilson, Cindy A, a další
  Vydáno: (2005)